Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 19, 2012 14:59 ET | Source: Marina Biotech, Inc.

Marina Biotech, Inc. to Raise $1.2 Million in Registered Direct Offering

BOTHELL, WA--(Marketwire - Mar 19, 2012) - Marina Biotech, Inc. (OTCQX: MRNA), a leading nucleic acid-based drug discovery and development company, announced that it has entered into definitive...
March 14, 2012 06:30 ET | Source: Marina Biotech, Inc.

Marina Biotech and ProNAi Therapeutics Announce License Agreement for the Development of DNAi-Based Therapeutics

BOTHELL, WA and ANN ARBOR, MI--(Marketwire - Mar 14, 2012) - Marina Biotech, Inc. (OTCQX: MRNA), a leading nucleic acid-based drug discovery and development company, and ProNAi Therapeutics, Inc....
February 29, 2012 07:30 ET | Source: Marina Biotech, Inc.

Marina Biotech Presents Advances in Oral Delivery of Nucleic Acids at AsiaTIDES Conference in Tokyo

BOTHELL, WA--(Marketwire - Feb 29, 2012) - Marina Biotech, Inc. (OTCQX: MRNA), a leading nucleic acid-based drug discovery and development company, today reported data demonstrating the continued...
February 22, 2012 06:30 ET | Source: Marina Biotech, Inc.

Marina Biotech Receives Notice of Allowance for U.S. Patent Related to Its Lipid Based Nucleic Acid Drug Delivery Platform

BOTHELL, WA--(Marketwire - Feb 22, 2012) - Marina Biotech, Inc. (OTCQX: MRNA), a leading nucleic acid-based drug discovery and development company, today announced that the U.S. Patent and...
February 14, 2012 06:30 ET | Source: Marina Biotech, Inc.

Marina Biotech Announces Closure of Cambridge Site and Consolidation of R&D Operations in Bothell, WA

BOTHELL, WA--(Marketwire - Feb 14, 2012) - Marina Biotech, Inc. (OTCQX: MRNA), a leading nucleic acid-based drug discovery and development company, today announced the closure of its Cambridge site...
February 10, 2012 06:30 ET | Source: Marina Biotech, Inc.

Marina Biotech Announces Closing of $1.5 MM Bridge Loan

BOTHELL, WA--(Marketwire - Feb 10, 2012) - Marina Biotech, Inc. (OTCQX: MRNA), a leading nucleic acid-based drug discovery and development company, today announced the closing of a bridge loan...
February 01, 2012 19:53 ET | Source: Marina Biotech, Inc.

Marina Biotech Begins Trading on the OTCQX Tier of OTC Market

BOTHELL, WA--(Marketwire - Feb 1, 2012) - Marina Biotech, Inc. (OTCQX: MRNA), a leading nucleic acid-based drug discovery and development company, today announced that the Company's common stock...
January 25, 2012 06:30 ET | Source: Marina Biotech, Inc.

Marina Biotech Starts Cohort 2 of Its Phase 1b START-FAP Clinical Trial of CEQ508

BOTHELL, WA--(Marketwire - Jan 25, 2012) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading nucleic acid-based drug discovery and development company, today announced that Cohort 2 in the Dose...
January 23, 2012 06:30 ET | Source: Marina Biotech, Inc.

Marina Biotech Receives Notice of Acceptance for Patent Broadly Covering Its Unlocked Nucleobase Analog (UNA) Technology

BOTHELL, WA--(Marketwire - Jan 23, 2012) - Marina Biotech, Inc. (NASDAQ: MRNAD), a leading oligonucleotide-based drug discovery and development company today announced that the Intellectual Property...
January 10, 2012 06:30 ET | Source: Marina Biotech, Inc.

Marina Biotech, Inc. Provides Update on Its Broad Nucleic Acid-Based Drug Discovery Platform and 2012 Goals

BOTHELL, WA--(Marketwire - Jan 10, 2012) - Marina Biotech, Inc. (NASDAQ: MRNAD), a leading oligonucleotide-based drug discovery and development company, will provide an update on its nucleic...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right